Viking Fund Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$768K Buy
18,000
+6,000
+50% +$268K 0.07% 126
2026
Q1
$578K Buy
+12,000
New +$560K 0.06% 127
2025
Q2
Sell
-3,000
Closed -$166K 146
2025
Q1
$166K Buy
+3,000
New +$162K 0.02% 131
2024
Q3
Sell
-2,200
Closed -$107K 136
2024
Q2
$107K Hold
2,200
0.02% 107
2024
Q1
$107K Buy
+2,200
New +$107K 0.02% 107
2023
Q4
Sell
-200
Closed -$10.7K 124
2023
Q3
$10.7K Hold
200
﹤0.01% 110
2023
Q2
$10.8K Buy
+200
New +$10.8K ﹤0.01% 117

Other funds holding SNY

Viking Fund Management's SNY Position: Q2 2026 in Review

Viking Fund Management increased its Sanofi (SNY) stake by 50% in Q2 2026, buying an estimated $268K and bringing the position to 18,000 shares worth $768K. The position accounts for 0.07% of the portfolio, ranked #126.

Viking Fund Management first reported a position in SNY in Q2 2023 and has held it in 7 quarters since. 104 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Viking Fund Management held 18,000 shares of Sanofi worth $768K as of Q2 2026.
  • Viking Fund Management bought 6,000 Sanofi shares in Q2 2026, an estimated $268K.
  • Sanofi made up 0.07% of Viking Fund Management's portfolio in Q2 2026, its #126 holding.
  • Viking Fund Management first reported a position in Sanofi in Q2 2023 and has held it in 7 quarters since.
  • 104 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Viking Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.